Pacific Biosciences Of California PACB
NASDAQ PACB
$2.13 -0.12 (-5.13%)
As of: Nov 11, 2026 · 2:51 PM EST

Pacific Biosciences Of California (PACB) Price to FCF (2020)

Updated

Pacific Biosciences Of California's Price to FCF was 270.15 in Q4 2020, up 120.2% from the prior quarter.

Analysis

Pacific Biosciences Of California (PACB) Price to FCF (2020) Analysis & Trends

From Q1 2020 onward, Pacific Biosciences Of California has reported Price to FCF for 4 quarters.

  • Per Business Quant data, PACB's Price to FCF in the three quarters before Q4 2020 was 122.71 (Q3 2020), 36.15 (Q2 2020) and 22.80 (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Pacific Biosciences Of California 699.41 Mn -292.35 Mn 13.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 270.15
Sep 30, 2020 122.71
Jun 30, 2020 36.15
Mar 31, 2020 22.80
API Access

Pacific Biosciences Of California Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=PACB&period=max&api_key=YOUR_API_KEY